ASTH
Price
$41.91
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
97 days until earnings call
LWSCF
Price
$11.92
Change
-$0.00 (-0.00%)
Updated
Nov 12 closing price
Ad is loading...

ASTH vs LWSCF

Header iconASTH vs LWSCF Comparison
Open Charts ASTH vs LWSCFBanner chart's image
Astrana Health
Price$41.91
Change-$0.00 (-0.00%)
Volume$585.78K
CapitalizationN/A
Sienna Sr Living
Price$11.92
Change-$0.00 (-0.00%)
Volume$201
CapitalizationN/A
ASTH vs LWSCF Comparison Chart
Loading...
ASTH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ASTH vs. LWSCF commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASTH is a Hold and LWSCF is a Hold.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (ASTH: $41.90 vs. LWSCF: $11.71)
Brand notoriety: ASTH and LWSCF are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: ASTH: 141% vs. LWSCF: 74%
Market capitalization -- ASTH: $1.88B vs. LWSCF: $631.7M
ASTH [@Medical/Nursing Services] is valued at $1.88B. LWSCF’s [@Medical/Nursing Services] market capitalization is $631.7M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $88.21B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $3.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASTH’s FA Score shows that 0 FA rating(s) are green whileLWSCF’s FA Score has 1 green FA rating(s).

  • ASTH’s FA Score: 0 green, 5 red.
  • LWSCF’s FA Score: 1 green, 4 red.
According to our system of comparison, LWSCF is a better buy in the long-term than ASTH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASTH’s TA Score shows that 4 TA indicator(s) are bullish.

  • ASTH’s TA Score: 4 bullish, 6 bearish.

Price Growth

ASTH (@Medical/Nursing Services) experienced а -29.08% price change this week, while LWSCF (@Medical/Nursing Services) price change was -4.49% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -3.60%. For the same industry, the average monthly price growth was -0.82%, and the average quarterly price growth was +1650.84%.

Reported Earning Dates

ASTH is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Medical/Nursing Services (-3.60% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ASTH($1.88B) has a higher market cap than LWSCF($632M). LWSCF has higher P/E ratio than ASTH: LWSCF (76.92) vs ASTH (32.55). LWSCF YTD gains are higher at: 38.011 vs. ASTH (9.399). ASTH has higher annual earnings (EBITDA): 124M vs. LWSCF (63.9M). ASTH has more cash in the bank: 296M vs. LWSCF (30.4M). ASTH has less debt than LWSCF: ASTH (321M) vs LWSCF (999M). ASTH has higher revenues than LWSCF: ASTH (1.39B) vs LWSCF (736M).
ASTHLWSCFASTH / LWSCF
Capitalization1.88B632M298%
EBITDA124M63.9M194%
Gain YTD9.39938.01125%
P/E Ratio32.5576.9242%
Revenue1.39B736M188%
Total Cash296M30.4M974%
Total Debt321M999M32%
FUNDAMENTALS RATINGS
ASTH vs LWSCF: Fundamental Ratings
ASTH
LWSCF
OUTLOOK RATING
1..100
5127
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
19
Undervalued
PROFIT vs RISK RATING
1..100
69100
SMR RATING
1..100
6488
PRICE GROWTH RATING
1..100
6346
P/E GROWTH RATING
1..100
8598
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LWSCF's Valuation (19) in the null industry is somewhat better than the same rating for ASTH (66). This means that LWSCF’s stock grew somewhat faster than ASTH’s over the last 12 months.

ASTH's Profit vs Risk Rating (69) in the null industry is in the same range as LWSCF (100). This means that ASTH’s stock grew similarly to LWSCF’s over the last 12 months.

ASTH's SMR Rating (64) in the null industry is in the same range as LWSCF (88). This means that ASTH’s stock grew similarly to LWSCF’s over the last 12 months.

LWSCF's Price Growth Rating (46) in the null industry is in the same range as ASTH (63). This means that LWSCF’s stock grew similarly to ASTH’s over the last 12 months.

ASTH's P/E Growth Rating (85) in the null industry is in the same range as LWSCF (98). This means that ASTH’s stock grew similarly to LWSCF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ASTH
RSI
ODDS (%)
Bullish Trend 1 day ago
70%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
69%
MACD
ODDS (%)
Bearish Trend 1 day ago
70%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
73%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
75%
Advances
ODDS (%)
Bullish Trend 9 days ago
79%
Declines
ODDS (%)
Bearish Trend 1 day ago
71%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
77%
Aroon
ODDS (%)
Bearish Trend 1 day ago
81%
View a ticker or compare two or three
Ad is loading...
ASTH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GCISX14.57N/A
N/A
Goldman Sachs Intl Eq Insghts S
AVPEX14.52-0.03
-0.21%
ALPS Global Opportunity III
SACVX35.21-0.10
-0.28%
Spirit of America Large Cap Value C
SSSVX448.31-2.69
-0.60%
State Street Equity 500 Index A
DRDAX27.10-0.17
-0.62%
Dearborn Partners Rising Dividend A

ASTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASTH has been loosely correlated with AMN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ASTH jumps, then AMN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASTH
1D Price
Change %
ASTH100%
-0.02%
AMN - ASTH
49%
Loosely correlated
-2.97%
CCRN - ASTH
47%
Loosely correlated
-0.89%
USPH - ASTH
39%
Loosely correlated
-1.84%
AVAH - ASTH
38%
Loosely correlated
-4.01%
SGRY - ASTH
35%
Loosely correlated
-2.88%
More

LWSCF and

Correlation & Price change

A.I.dvisor tells us that LWSCF and ASTH have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LWSCF and ASTH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LWSCF
1D Price
Change %
LWSCF100%
N/A
ASTH - LWSCF
21%
Poorly correlated
-2.24%
MFCSF - LWSCF
16%
Poorly correlated
+1.59%
LTGHY - LWSCF
16%
Poorly correlated
-2.03%
HLYK - LWSCF
10%
Poorly correlated
+5.26%
NWKHY - LWSCF
5%
Poorly correlated
N/A
More